Daiwa Securities Group Inc. Has $2.13 Million Position in CME Group Inc (CME)
Daiwa Securities Group Inc. boosted its position in CME Group Inc (NASDAQ:CME) by 2.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 14,590 shares of the financial services provider’s stock after acquiring an additional 362 shares during the quarter. Daiwa Securities Group Inc.’s holdings in CME Group were worth $2,131,000 at the end of the most recent quarter.
A number of other large investors have also recently modified their holdings of CME. Scotia Capital Inc. acquired a new stake in CME Group in the second quarter valued at approximately $211,000. Koch Industries Inc. raised its holdings in CME Group by 16,136.1% during the second quarter. Koch Industries Inc. now owns 278,612 shares of the financial services provider’s stock worth $276,000 after purchasing an additional 276,896 shares in the last quarter. Cetera Investment Advisers acquired a new stake in CME Group during the second quarter worth approximately $242,000. Intl Fcstone Inc. acquired a new stake in CME Group during the second quarter worth approximately $1,176,000. Finally, Crow Point Partners LLC raised its holdings in CME Group by 9.6% during the third quarter. Crow Point Partners LLC now owns 5,909 shares of the financial services provider’s stock worth $803,000 after purchasing an additional 519 shares in the last quarter. 82.85% of the stock is currently owned by hedge funds and other institutional investors.
In other news, insider Sunil Cutinho sold 2,600 shares of the firm’s stock in a transaction that occurred on Friday, November 17th. The shares were sold at an average price of $139.57, for a total transaction of $362,882.00. Following the transaction, the insider now directly owns 22,301 shares in the company, valued at $3,112,550.57. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Also, Chairman Terrence A. Duffy sold 20,000 shares of the firm’s stock in a transaction that occurred on Tuesday, February 6th. The stock was sold at an average price of $151.66, for a total transaction of $3,033,200.00. Following the transaction, the chairman now owns 99,239 shares in the company, valued at $15,050,586.74. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 67,128 shares of company stock worth $10,086,157. Insiders own 0.57% of the company’s stock.
CME Group (NASDAQ:CME) last announced its earnings results on Thursday, February 1st. The financial services provider reported $1.12 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.10 by $0.02. The business had revenue of $900.00 million for the quarter, compared to analyst estimates of $886.85 million. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The company’s revenue for the quarter was down 1.4% compared to the same quarter last year. During the same period last year, the firm posted $1.14 earnings per share. research analysts predict that CME Group Inc will post 6.32 EPS for the current year.
The firm also recently announced a quarterly dividend, which will be paid on Monday, March 26th. Stockholders of record on Friday, March 9th will be given a dividend of $0.70 per share. The ex-dividend date is Thursday, March 8th. This is a positive change from CME Group’s previous quarterly dividend of $0.66. This represents a $2.80 dividend on an annualized basis and a dividend yield of 1.73%. CME Group’s dividend payout ratio (DPR) is 22.11%.
CME has been the topic of a number of research analyst reports. Bank of America raised their price objective on shares of CME Group from $173.00 to $175.00 and gave the stock a “buy” rating in a report on Friday, February 2nd. Zacks Investment Research raised shares of CME Group from a “hold” rating to a “buy” rating and set a $164.00 price objective on the stock in a report on Tuesday, January 2nd. BidaskClub cut shares of CME Group from a “strong-buy” rating to a “buy” rating in a report on Wednesday, October 18th. Sandler O’Neill reissued a “buy” rating and set a $175.00 price objective on shares of CME Group in a report on Friday, February 2nd. Finally, Barclays raised their price objective on shares of CME Group from $170.00 to $175.00 and gave the stock an “overweight” rating in a report on Friday, February 2nd. Three research analysts have rated the stock with a hold rating, eleven have assigned a buy rating and one has issued a strong buy rating to the company. CME Group has a consensus rating of “Buy” and an average target price of $157.00.
CME Group Company Profile
CME Group Inc, through its exchanges, provides products across all asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products and metals. The Company’s segment primarily consists of the Chicago Mercantile Exchange Inc (CME), Board of Trade of the City of Chicago, Inc (CBOT), New York Mercantile Exchange, Inc (NYMEX) and Commodity Exchange, Inc (COMEX) exchanges.
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc (NASDAQ:CME).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.